cefixime has been researched along with Tonsillitis in 12 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Tonsillitis: Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 9.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "The clinical efficacy and safety of cefixime (CFIX), a new oral cephalosporin, were compared with those of cefroxadine (CXD) in patients suffering from acute lacunar tonsillitis in a double blind study." | 9.06 | [A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis]. ( Asai, H; Itoh, Y; Kawamura, S; Kobayashi, K; Matsunaga, T; Ogino, H; Onishi, S; Sakamoto, Y; Shiraishi, T; Ueda, R, 1987) |
| "Cefixime was administered for five to twelve days twice daily in a dose of 200 mg." | 6.67 | [Cefixime treatment in different bacterial infections in the ENT region]. ( Benner, U; Blessing, R; Pelz, K; Schlenter, WW, 1990) |
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 5.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "The clinical efficacy and safety of cefixime (CFIX), a new oral cephalosporin, were compared with those of cefroxadine (CXD) in patients suffering from acute lacunar tonsillitis in a double blind study." | 5.06 | [A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis]. ( Asai, H; Itoh, Y; Kawamura, S; Kobayashi, K; Matsunaga, T; Ogino, H; Onishi, S; Sakamoto, Y; Shiraishi, T; Ueda, R, 1987) |
| "The absorption and excretion and clinical effectiveness of cefixime (CFIX) granules, a new oral cephalosporin, were studied with pediatric patients with tonsillitis and urinary tract infection (UTI)." | 3.67 | [Clinical study on cefixime granules in the field of pediatrics]. ( Haruta, T; Kobayashi, Y; Kuroki, S, 1986) |
| "Cefixime (CFIX) was given orally to 25 children with acute bacterial infections including 13 with acute tonsillitis, 1 with acute tonsillitis and cervical lymphadenitis, 1 with acute bronchitis, 5 with bronchopneumonia and 5 with urinary tract infection." | 3.67 | [Clinical experience with cefixime in the pediatric field]. ( Aihara, R; Kobashi, H; Nishioka, A; Ohara, K; Okamoto, T, 1986) |
| "Cefixime was administered for five to twelve days twice daily in a dose of 200 mg." | 2.67 | [Cefixime treatment in different bacterial infections in the ENT region]. ( Benner, U; Blessing, R; Pelz, K; Schlenter, WW, 1990) |
| "Twenty-one pediatric patients with bacterial infections (10, tonsillitis; 4, pharyngitis; and 7, urinary tract infections) were treated with CFIX at doses of 1." | 1.27 | [Fundamental and clinical studies on cefixime in the pediatric field]. ( Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T, 1986) |
| "Cefixime (CFIX) was evaluated for pharmacokinetics, therapeutic effectiveness on infection, safety, and bacteriological effectiveness in pediatrics." | 1.27 | [Fundamental and clinical studies on cefixime in pediatric field]. ( Kida, K; Matsuda, H; Miyazaki, M; Murase, M, 1986) |
| " The mean half-life and the mean AUC values were 2." | 1.27 | [Pharmacokinetics and clinical effects of cefixime in pediatrics]. ( Ishimoto, K; Koga, T; Motohiro, T; Nagayama, K; Nishiyama, T; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S; Yamashita, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, D | 1 |
| Hostalek, U | 1 |
| Tröster, K | 1 |
| Di Nola, F | 1 |
| Arione, R | 1 |
| Bramato, C | 1 |
| Schlenter, WW | 1 |
| Blessing, R | 1 |
| Pelz, K | 1 |
| Benner, U | 1 |
| Scott, HV | 1 |
| Pannowitz, D | 1 |
| Ketelbey, JW | 1 |
| Matsunaga, T | 1 |
| Ogino, H | 1 |
| Asai, H | 1 |
| Shiraishi, T | 1 |
| Kawamura, S | 1 |
| Onishi, S | 1 |
| Ueda, R | 1 |
| Kobayashi, K | 1 |
| Itoh, Y | 1 |
| Sakamoto, Y | 1 |
| Nishimura, T | 1 |
| Takashima, T | 1 |
| Tabuki, K | 1 |
| Takagi, M | 1 |
| Nakashima, S | 1 |
| Hayakawa, F | 1 |
| Nakashima, T | 1 |
| Miyachi, Y | 1 |
| Hakamada, S | 1 |
| Kuno, K | 1 |
| Haruta, T | 1 |
| Kuroki, S | 1 |
| Kobayashi, Y | 1 |
| Furukawa, S | 1 |
| Okada, T | 1 |
| Aihara, R | 1 |
| Kobashi, H | 1 |
| Nishioka, A | 1 |
| Ohara, K | 1 |
| Okamoto, T | 1 |
| Miyazaki, M | 1 |
| Kida, K | 1 |
| Matsuda, H | 1 |
| Murase, M | 1 |
| Motohiro, T | 1 |
| Tanaka, K | 1 |
| Koga, T | 1 |
| Shimada, Y | 1 |
| Tomita, S | 1 |
| Nishiyama, T | 1 |
| Ishimoto, K | 1 |
| Tominaga, K | 1 |
| Yamashita, F | 1 |
| Nagayama, K | 1 |
1 review available for cefixime and Tonsillitis
| Article | Year |
|---|---|
[Cefixime. Microbiologic, kinetic and clinical profile].
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Gonorrhea; Humans; Microbial Sensitivity Tests; Otitis Medi | 1991 |
4 trials available for cefixime and Tonsillitis
| Article | Year |
|---|---|
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicil | 1995 |
[Cefixime treatment in different bacterial infections in the ENT region].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance | 1990 |
Cefixime: clinical trial against otitis media and tonsillitis.
Topics: Administration, Oral; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Administration Schedule; D | 1990 |
[A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis].
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Clinical Trials as Topic; Double-Bl | 1987 |
7 other studies available for cefixime and Tonsillitis
| Article | Year |
|---|---|
[Clinical studies of cefixime in pediatric field].
Topics: Acute Disease; Adolescent; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; Chil | 1986 |
[Fundamental and clinical studies on cefixime in the pediatric field].
Topics: Acute Disease; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female | 1986 |
[Clinical study on cefixime granules in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Clinical experience with cefixime in the pediatric infections].
Topics: Acute Disease; Adolescent; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-L | 1986 |
[Clinical experience with cefixime in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchopneumonia; Cefixime; Cefotaxime; Child; Chil | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Femal | 1986 |
[Pharmacokinetics and clinical effects of cefixime in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Pre | 1986 |